TM5275, a carboxylic acid derivatives, inherited from the previous TM5001 and TM5007, showed potent antithrombotic ability in rats and non-human primates, and was also shown to block TGF-B1-induced pulmonary fibrosis. This evidence concerns the gene TGFB1 and pulmonary fibrosis.